Newsfile Corp
21 Oct 2026, 07:50 UTC · 1h ago
Impact · against what's priced in
Unicycive Therapeutics faces a new class action lawsuit regarding securities purchased between December 2025 and June 2026. This introduces potential legal liabilities and settlement costs that may compress the company's cash runway.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Kaplan Fox & Kilsheimer LLP filed a class action lawsuit against Unicycive Therapeutics (UNCY) regarding securities purchased between December 29, 2025 and June 29, 2026.
Newannouncement dated October 21, 2026
So whatLegal reserves for potential settlements may impact the cash runway and net income for FY2027.
More negative than 75% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The filing of a class action lawsuit by Kaplan Fox creates a new legal liability that could impact future net income and available cash reserves.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit filed on behalf of investors who suffered losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
5h ago
—
UNCY hasn't traded since this ran. Last close $3.80 (Oct 20); the reaction starts at the next open.
UNCY chart →
